Nonalcoholic Steatohepatitis Completed Phase 1 / 2 Trials for Fluorescein lisicol (DB12030)

IndicationStatusPhase
DBCOND0029353 (Nonalcoholic Steatohepatitis)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00856869Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy VolunteersDiagnostic